Nurix Therapeutics
NRIX
NRIX
118 hedge funds and large institutions have $561M invested in Nurix Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% less capital invested
Capital invested by funds: $568M → $561M (-$7.2M)
8.58% less ownership
Funds ownership: 100.1% → 91.52% (-8.6%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
118
Holding in Top 10
2
Calls
$1.74M
Puts
$1K
Top Buyers
| 1 | +$6.62M | |
| 2 | +$6.43M | |
| 3 | +$5.14M | |
| 4 |
BlackRock
New York
|
+$4.79M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.97M |
Top Sellers
| 1 | -$24.4M | |
| 2 | -$14.6M | |
| 3 | -$13.2M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$8.58M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.39M |